Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: Lipo-MGN nanoparticle hypoxia attenuation-mediated single-dose radiotherapy- and pH/ROS-responsive T1 contrast magnetic resonance imaging in hepatocellular carcinoma

Fig. 7

In vivo MR imaging of nu BALB/C mice injected with Lipo-MGNs at different time points. A T1-weighted MR contrast images of mice 1, 2 and 3 (m1, m2, m3) at different time points. B T1 contrast intensity ratios pre-injection and post-injection of Lipo-MGNs. The data are presented as the mean ± standard deviation with number of samples (n) = 3. The mean signal intensity showed significant differences between the pre-injection and post-injection time points (3, 6, 8 and 24 h) as analyzed by the Student’s unpaired t-test. A two-tailed probability value (p) < 0.05 was considered statistically significant. *Indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001

Back to article page